Fig. 4From: Gefitinib provides similar effectiveness and improved safety than erlotinib for east Asian populations with advanced non–small cell lung cancer: a meta-analysisForest plots of RR of ORR (a) and DCR (b) associated with gefitinib versus erlotinibBack to article page